Targeting US$610 billion longevity market, biotech firms race to reverse ageing

AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.